The All India Organization of Chemists and Druggists (AIOCD) called for a statewide strike on Tuesday, raising concerns about potential interruptions to access to medications in various regions of India. Numerous chemists' groups are supporting the protest, which is aimed at internet pharmacies and digital pharmaceutical delivery platforms and might have an effect on thousands of individual medical businesses. The fast growth of e-pharmacies is occurring without sufficient regulatory controls, according to the AIOCD, which claims to represent over 12.4 lakh chemists and drug distributors nationally. The organization has expressed concerns regarding cold-chain management during delivery, online access to restricted medications, prescription verification, and purported abuse of digital medical platforms.

Nonetheless, patients have been reassured that access to necessary medications will continue by the federal government and a number of state governments. Despite the closure, it is anticipated that hospital-affiliated pharmacies, Jan Aushadhi Kendras, AMRIT pharmacies, and a number of significant pharmacy chains will continue to operate.
Why Have Chemists Declared a National Strike?
The "unregulated" operation of e-pharmacy platforms and online medication delivery services, according to chemists, is the reason behind the strike.
AIOCD executives claim that the Drugs and Cosmetics Act's stringent regulations, which include prescription verification and thorough record-keeping for prohibited medications like antibiotics, opioids, and abortion medication, apply to retail pharmacies.AIOCD General Secretary Prabhakar Kumar told ANI that while internet medicine sales are claimed to lack comparable precautions, traditional pharmacies must keep separate registers and save copies of doctor's prescriptions for a number of regulated drugs.Strict documentation and legitimate prescriptions are necessary for the medications we sell. However, he claimed that it is easier to obtain drugs, such as medications and alcohol, online, sometimes with fictitious prescriptions.
The 2018 draft notification GSR 817(E), which suggested a regulatory framework for e-pharmacies, is also connected to the protest. Chemists contend that despite the framework's incomplete implementation, online drug sales are nonetheless growing without thorough regulation.

Issues with the Delivery of Medicines Online
Concerns about patient safety and medication quality have been voiced by pharmacy associations.
The potential for fake medications, recurrent use of outdated prescriptions, and unlawful access to Schedule H substances via internet platforms are some of the major concerns raised by chemists.
Concerns about medications that are sensitive to temperature have also been raised by industry groups. According to Prasanna Kumar Singh, President of the Bihar Chemists and Druggists Association, medications that need to be kept in a cold chain, such insulin, vaccinations, and some biologics, could become less effective if they are sent by courier.
Chemists additionally claim that the viability of local neighbourhood pharmacies, especially in semi-urban and rural areas, is being impacted by heavy discounting methods by giant e-pharmacy corporations.Will There Be a Shortage of Medicines for Patients?
It is anticipated that the strike's real effects will differ by state.
To guarantee continuous access to medications, a number of state governments and drug authorities have implemented emergency procedures. Hospital pharmacies, large chain pharmacies, cooperative pharmacies, and Jan Aushadhi Kendras would continue to operate throughout the shutdown, according to sources.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana Kendras, including stores at important hospitals like AIIMS and Patna Medical College and Hospital, would continue to operate, according to the PMBJK Retailer Association.
About 5,000 pharmacies in Tamil Nadu are anticipated to stay open in spite of the strike, according to the Drugs Control Department. In order to address issues pertaining to the supply of medications, the state government has also established district-level hotlines run by Assistant Directors and Drug Inspectors.

Hospital supplies and emergency medications are not anticipated to be greatly impacted, according to officials.
However, patients who depend on regular or chronic drugs may experience short-term inconvenience in places where many private pharmacies are still closed. Patients are being advised by medical professionals not to put off getting refills for necessary medications.
The More Comprehensive Discussion Regarding E-Pharmacies
The demonstration has brought attention to the ongoing discussion in India regarding the regulation of online pharmacies.
Due to the ease of home delivery, lower prices, and more internet access, digital pharmaceutical platforms grew quickly both during and after the Covid-19 outbreak. Online pharmacies, according to public health experts, can help older patients, those with disabilities, and those who live in rural places have better access to medications.

In order to stop abuse, experts have recommended for more stringent oversight on several occasions.
The World Health Organization (WHO) has cautioned that phoney and subpar medications continue to pose a serious hazard to public health worldwide, particularly in places with lax regulatory frameworks. Additionally, medical professionals warn that improper online access to drugs may exacerbate antimicrobial resistance.
According to policy experts, India urgently needs a robust regulatory framework that regulates the quickly expanding digital pharmacy industry while striking a balance between patient safety, prescription monitoring, and accessibility.
The growing conflict between traditional pharmacies and India's growing e-pharmacy sector is reflected in the statewide chemists' strike. Chemists contend that there are now insufficient security measures in place for online drug transactions, yet digital platforms are nonetheless becoming more and more popular due to their affordability and ease.

Due to ongoing operations at hospital pharmacies, Jan Aushadhi Kendras, and large pharmacy chains, the immediate impact on patients is anticipated to be minimal in the majority of locations. It is unlikely that the broader policy discussion surrounding e-pharmacy regulation will conclude anytime soon, though.